Aaron Wood, Eli Lilly & Company


Vision and Discrete Sensors March 1, 2009

Generic Batch Procedures for Flexible Manufacturing

Transforming a pharmaceutical manufacturing facility from a multiple-campaign, multiple established product-based operation, to one that can also accommodate single-development product campaigns is a challenge. Even so, this feat was accomplished successfully at one of Eli Lilly’s bulk pharmaceutical production buildings. See diagram.

By Aaron Wood, Eli Lilly & Company